Loading...

Dr. Tevi Troy on FDA & CER Communications Challenges

103 views

Loading...

Loading...

Transcript

The interactive transcript could not be loaded.

Loading...

Loading...

Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Uploaded on Feb 17, 2012

Dr. Tevi Troy, senior fellow at the Hudson Institute and former deputy secretary of the US Department of Health and Human Services, says that it can be challenging for pharmaceutical companies to respond to comparative effectiveness research (CER) findings. He says that the Food and Drug Administration (FDA) should provide clear guidance as to how and when companies will be able to respond. Dr. Troy spoke during a Feb. 2012 meeting, "Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making."

For more information, visit http://www.npcnow.org/issue/communica....

Loading...

When autoplay is enabled, a suggested video will automatically play next.

Up next


to add this to Watch Later

Add to

Loading playlists...